Key Market Indicators
Sales of analgesic medicines in Slovakia are forecast to reach $60 million by 2026, up from $54 million in 2021. This represents a year-on-year increase of 1.9% over the five years to 2026. Since 2001, the Slovak market has grown by an average of 3.7% each year. In 2021, it ranked 18th in the world, behind Ireland, which reported sales of $54 million. Spain, Canada and Italy filled the next three places in the rankings.
